GlobeNewswire Inc.··NaMetagenomi's Compact CRISPR Breakthrough Achieves 64% Protein Knockdown in Mice
Metagenomi's compact CRISPR nuclease achieves 64% protein knockdown in mice via single AAV injection, validating its approach for non-hepatic genome editing therapies.
MGXin vivo gene editingneuromuscular disease